Differences in caecal microbiota composition and Salmonella carriage between experimentally infected inbred lines of chickens.


Journal

Genetics, selection, evolution : GSE
ISSN: 1297-9686
Titre abrégé: Genet Sel Evol
Pays: France
ID NLM: 9114088

Informations de publication

Date de publication:
29 Jan 2022
Historique:
received: 15 04 2021
accepted: 17 01 2022
entrez: 30 1 2022
pubmed: 31 1 2022
medline: 2 2 2022
Statut: epublish

Résumé

Salmonella Enteritidis (SE) is one of the major causes of human foodborne intoxication resulting from consumption of contaminated poultry products. Genetic selection of animals that are more resistant to Salmonella carriage and modulation of the gut microbiota are two promising ways to decrease individual Salmonella carriage. The aims of this study were to identify the main genetic and microbial factors that control the level of Salmonella carriage in chickens (Gallus gallus) under controlled experimental conditions. Two-hundred and forty animals from the White Leghorn inbred lines N and 6 Our results confirmed that the N line is more resistant to Salmonella carriage than the 6 Overall, our findings demonstrate that the caecal microbiota composition differs between genetic lines of chickens. This could be one of the reasons why the investigated lines differed in Salmonella carriage levels under experimental infection conditions.

Sections du résumé

BACKGROUND BACKGROUND
Salmonella Enteritidis (SE) is one of the major causes of human foodborne intoxication resulting from consumption of contaminated poultry products. Genetic selection of animals that are more resistant to Salmonella carriage and modulation of the gut microbiota are two promising ways to decrease individual Salmonella carriage. The aims of this study were to identify the main genetic and microbial factors that control the level of Salmonella carriage in chickens (Gallus gallus) under controlled experimental conditions. Two-hundred and forty animals from the White Leghorn inbred lines N and 6
RESULTS RESULTS
Our results confirmed that the N line is more resistant to Salmonella carriage than the 6
CONCLUSIONS CONCLUSIONS
Overall, our findings demonstrate that the caecal microbiota composition differs between genetic lines of chickens. This could be one of the reasons why the investigated lines differed in Salmonella carriage levels under experimental infection conditions.

Identifiants

pubmed: 35093028
doi: 10.1186/s12711-022-00699-6
pii: 10.1186/s12711-022-00699-6
pmc: PMC8801081
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7

Informations de copyright

© 2022. The Author(s).

Références

FEMS Immunol Med Microbiol. 2012 Jul;65(2):360-5
pubmed: 22448648
Cell Tissue Res. 2011 Jan;343(1):23-32
pubmed: 20941511
Poult Sci. 2002 Nov;81(11):1653-60
pubmed: 12455592
Front Vet Sci. 2017 Nov 13;4:192
pubmed: 29181381
Appl Environ Microbiol. 2015 Dec 28;82(5):1569-76
pubmed: 26712550
Anim Genet. 2009 Oct;40(5):590-7
pubmed: 19422366
Microbiome. 2018 May 1;6(1):81
pubmed: 29716650
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Bioinformatics. 2018 Apr 15;34(8):1287-1294
pubmed: 29228191
Sci Rep. 2013;3:1163
pubmed: 23362462
PLoS One. 2013 Dec 31;8(12):e84290
pubmed: 24391931
PLoS One. 2015 Aug 12;10(8):e0135488
pubmed: 26267269
Poult Sci. 2001 Aug;80(8):1105-8
pubmed: 11495461
Vet Res. 2010 Sep-Oct;41(5):68
pubmed: 20609329
Animals (Basel). 2019 Aug 27;9(9):
pubmed: 31462004
Mol Genet Genomics. 2011 Mar;285(3):237-43
pubmed: 21279652
Vet Immunol Immunopathol. 2018 Oct;204:44-51
pubmed: 30596380
Vet Immunol Immunopathol. 2014 May 15;159(1-2):16-28
pubmed: 24694400
BMC Genomics. 2015 May 28;16:418
pubmed: 26017153
Cell Host Microbe. 2013 Jul 17;14(1):26-37
pubmed: 23870311
Cell Host Microbe. 2019 Jan 9;25(1):128-139.e5
pubmed: 30629913
Genet Sel Evol. 2005 Sep-Oct;37(5):539-61
pubmed: 16093014
Appl Environ Microbiol. 2020 Mar 18;86(7):
pubmed: 31980428
Appl Environ Microbiol. 2013 Jan;79(2):745-7
pubmed: 23144133
PeerJ. 2014 Sep 25;2:e593
pubmed: 25276506
Microbiome. 2018 Jun 23;6(1):115
pubmed: 29935540
Nature. 2010 Sep 23;467(7314):426-9
pubmed: 20864996
Microb Pathog. 2019 May;130:54-58
pubmed: 30831229
Microb Pathog. 2019 Jul;132:325-334
pubmed: 31082529
Front Microbiol. 2016 Jun 17;7:957
pubmed: 27379083
Nucleic Acids Res. 2018 Jan 4;46(D1):D633-D639
pubmed: 29059334
Curr Biol. 2016 Jun 6;26(11):1480-5
pubmed: 27185560
Pol J Vet Sci. 2019 Mar;22(1):5-10
pubmed: 30997761
Vet Immunol Immunopathol. 2010 May 15;135(1-2):52-63
pubmed: 19945754
Microb Biotechnol. 2020 Sep;13(5):1611-1630
pubmed: 32639676
Poult Sci. 2019 Feb 1;98(2):695-706
pubmed: 30247675
Cell. 2014 Nov 6;159(4):789-99
pubmed: 25417156
Poult Sci. 2019 Sep 1;98(9):4084-4093
pubmed: 31330021
Vet J. 2000 Mar;159(2):111-23
pubmed: 10712799
Poult Sci. 2019 Oct 1;98(10):4449-4456
pubmed: 31162611
Front Vet Sci. 2015 Nov 23;2:61
pubmed: 26664988
Poult Sci. 2003 May;82(5):721-6
pubmed: 12762392
Microbiome. 2015 Nov 10;3:51
pubmed: 26552373
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
PLoS One. 2014 Mar 07;9(3):e89862
pubmed: 24608294
Int J Food Microbiol. 2003 Aug 25;85(3):237-48
pubmed: 12878382
Poult Sci. 2018 Sep 1;97(9):3009-3014
pubmed: 29800328
Environ Microbiol. 2018 Sep;20(9):3246-3260
pubmed: 29921019
mSystems. 2019 Apr 23;4(2):
pubmed: 31020042
BMJ. 2018 Jun 13;361:k2179
pubmed: 29899036
Poult Sci. 2019 Apr 1;98(4):1785-1790
pubmed: 30535349
Vet Microbiol. 2009 Mar 30;135(3-4):187-95
pubmed: 19185433
J Clin Microbiol. 2002 Aug;40(8):3050-2
pubmed: 12149377
Microb Pathog. 2018 Sep;122:174-179
pubmed: 29906541
FEMS Microbiol Lett. 2014 Nov;360(2):100-12
pubmed: 25263745
EFSA J. 2021 Feb 27;19(2):e06406
pubmed: 33680134
BMC Biol. 2019 Oct 28;17(1):83
pubmed: 31660948
Poult Sci. 2019 Mar 1;98(3):1235-1242
pubmed: 30265331
Genet Sel Evol. 2002 Mar-Apr;34(2):211-9
pubmed: 12081808
Benef Microbes. 2016 Feb;7(1):11-22
pubmed: 26565087
Science. 2016 Apr 29;352(6285):532-5
pubmed: 27126034
Nat Methods. 2013 Jan;10(1):57-9
pubmed: 23202435
Anim Microbiome. 2020 Jan 16;2(1):2
pubmed: 33499995
Int J Med Microbiol. 2008 Jul;298(5-6):429-39
pubmed: 17888732
Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):423-8
pubmed: 12072268
Animals (Basel). 2020 Jan 08;10(1):
pubmed: 31936291
BMC Vet Res. 2013 Jul 15;9:140
pubmed: 23856245
Immunity. 2019 Feb 19;50(2):432-445.e7
pubmed: 30683619
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Gut Pathog. 2018 Aug 03;10:34
pubmed: 30087697
Nature. 1973 Jan 19;241(5386):210-1
pubmed: 4700893
Poult Sci. 2018 Mar 1;97(3):1006-1021
pubmed: 29253263
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Sci Rep. 2020 Mar 16;10(1):4809
pubmed: 32179754

Auteurs

Anaïs Cazals (A)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.
Mouse Genetics Laboratory, Department of Genomes and Genetics, Institut Pasteur, Paris, France.

Jordi Estellé (J)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Nicolas Bruneau (N)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Jean-Luc Coville (JL)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Pierrette Menanteau (P)

Université François Rabelais de Tours, INRAE, UMR ISP, 37380, Nouzilly, France.

Marie-Noëlle Rossignol (MN)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Deborah Jardet (D)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Claudia Bevilacqua (C)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Andrea Rau (A)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Bertrand Bed'Hom (B)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France.

Philippe Velge (P)

Université François Rabelais de Tours, INRAE, UMR ISP, 37380, Nouzilly, France.

Fanny Calenge (F)

Université Paris-Saclay, INRAE, AgroParisTech, GABI, 78350, Jouy-en-Josas, France. fanny.calenge@inrae.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH